Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
JAMA. 2010 Aug 11;304(6):641-8. doi: 10.1001/jama.2010.1115.
Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen of public health importance; MRSA prevention programs that may affect MRSA transmission and infection are increasingly common in health care settings. Whether there have been changes in MRSA infection incidence as these programs become established is unknown; however, recent data have shown that rates of MRSA bloodstream infections (BSIs) in intensive care units are decreasing.
To describe changes in rates of invasive health care-associated MRSA infections from 2005 through 2008 among residents of 9 US metropolitan areas.
DESIGN, SETTING, AND PARTICIPANTS: Active, population-based surveillance for invasive MRSA in 9 metropolitan areas covering a population of approximately 15 million persons. All reports of laboratory-identified episodes of invasive (from a normally sterile body site) MRSA infections from 2005 through 2008 were evaluated and classified based on the setting of the positive culture and the presence or absence of health care exposures. Health care-associated infections (ie, hospital-onset and health care-associated community-onset), which made up 82% of the total infections, were included in this analysis.
Change in incidence of invasive health care-associated MRSA infections and health care-associated MRSA BSIs using population of the catchment area as the denominator.
From 2005 through 2008, there were 21,503 episodes of invasive MRSA infection; 17,508 were health care associated. Of these, 15,458 were MRSA BSIs. The incidence rate of hospital-onset invasive MRSA infections was 1.02 per 10,000 population in 2005 and decreased 9.4% per year (95% confidence interval [CI], 14.7% to 3.8%; P = .005), and the incidence of health care-associated community-onset infections was 2.20 per 10,000 population in 2005 and decreased 5.7% per year (95% CI, 9.7% to 1.6%; P = .01). The decrease was most prominent for the subset of infections with BSIs (hospital-onset: -11.2%; 95% CI -15.9% to -6.3%; health care-associated community-onset: -6.6%; 95% CI -9.5% to -3.7%).
Over the 4-year period from 2005 through 2008 in 9 diverse metropolitan areas, rates of invasive health care-associated MRSA infections decreased among patients with health care-associated infections that began in the community and also decreased among those with hospital-onset invasive disease.
耐甲氧西林金黄色葡萄球菌(MRSA)是具有公共卫生重要性的病原体;在医疗机构中,越来越多地采用可能影响 MRSA 传播和感染的 MRSA 预防方案。这些方案建立后,MRSA 感染发病率是否发生了变化尚不清楚;然而,最近的数据显示,重症监护病房(ICU)中耐甲氧西林金黄色葡萄球菌血流感染(BSI)的发生率正在下降。
描述 2005 年至 2008 年间美国 9 个大都市地区居民中侵袭性与医疗保健相关的 MRSA 感染率的变化。
设计、地点和参与者:对 9 个大都市地区进行侵袭性 MRSA 的主动、基于人群的监测,这些地区的人口约为 1500 万人。评估和分类 2005 年至 2008 年间所有实验室鉴定的侵袭性(来自正常无菌部位)MRSA 感染病例,依据阳性培养物的部位和有无医疗保健暴露进行分类。本分析包括 82%的总感染病例,即医疗保健相关性感染(即医院获得性和医疗保健相关性社区获得性)。
使用监测区域人口作为分母,评估侵袭性医疗保健相关 MRSA 感染和医疗保健相关 MRSA BSI 的发病率变化。
2005 年至 2008 年期间,共有 21503 例侵袭性 MRSA 感染病例;其中 17508 例为医疗保健相关性。其中,15458 例为耐甲氧西林金黄色葡萄球菌 BSI。2005 年,医院获得性侵袭性 MRSA 感染的发病率为每 10000 人口 1.02 例,每年下降 9.4%(95%置信区间[CI],14.7%至 3.8%;P =.005),医疗保健相关性社区获得性感染的发病率为每 10000 人口 2.20 例,每年下降 5.7%(95% CI,9.7%至 1.6%;P =.01)。BSI 感染亚组的下降最为显著(医院获得性:-11.2%;95% CI-15.9%至-6.3%;医疗保健相关性社区获得性:-6.6%;95% CI-9.5%至-3.7%)。
在 2005 年至 2008 年的 4 年期间,在 9 个不同大都市地区,社区获得性起始的医疗保健相关感染和医院获得性侵袭性疾病患者的侵袭性医疗保健相关 MRSA 感染率均有所下降。